Clinical Trial: The ILet Experience Study

U.S., March 25 -- ClinicalTrials.gov registry received information related to the study (NCT06891898) titled 'The ILet Experience Study' on March 18.

Brief Summary: A one-year, prospective single-arm cohort study to collect safety and effectiveness data on the iLet Dosing Decision Software during real-world use in people 6 years of age or older with type 1 diabetes (T1D) with 12 months follow-up.

Study Start Date: May 01, 2024

Study Type: OBSERVATIONAL

Condition: Type 1 Diabetes

Intervention: DEVICE: iLet Dosing Decision Software

Interoperable alternate glycemic controller

Recruitment Status: RECRUITING

Sponsor: Beta Bionics, Inc.

Published by HT Digital Content Services with permission from Health Daily Digest....